Work

Sacituzumab govitecan initial dose reduction in Polish patients with metastatic triple-negative breast cancer: Impact on efficacy and safety.

Year: 2025

Type: article

Study design: Observational Study

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.e13136

Authors: Miroslawa Puskulluoglu, Anna Polakiewicz-Gilowska, Manuela Las-Jankowska, Renata Pacholczak-Madej, Paulina Kilian-Van Miegem, Marek Ziobro, Michal Jarzab, Aleksandra Łacko, Małgorzata Pieniążek

Institutions: The Maria Sklodowska-Curie National Research Institute of Oncology, Centrum Onkologii, Wroclaw Medical University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410804635

FWCI:

Cites:

Cited by:

Related to: 10